FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940904211> ?p ?o ?g. }

• W2940904211 endingPage "682" @default.
• W2940904211 startingPage "674" @default.
• W2940904211 abstract "Context Carcinoma in situ (CIS) of the bladder is defined as a high-grade flat lesion confined to the mucosa. Intravesical treatment with bacillus Calmette–Guérin (BCG) is commonly used to reduce the risk of recurrence and progression; however, CIS of the bladder exhibits a heterogeneous clinical behavior and a significant proportion of patients do not show a primary response. Objective To evaluate the available evidence concerning diagnosis, treatment strategies, follow-up, prognosis, and oncological outcomes in patients with CIS of the bladder. Evidence acquisition A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search was conducted using the databases PubMed/MEDLINE and Embase. We included randomized controlled trials, systematic reviews, meta-analyses, and observational studies. Outcomes of interest were: (1) diagnostic strategies, (2) first- and second-line treatments, (3) follow-up strategies, and (4) prognosis and oncological outcomes. Evidence synthesis Overall 62 articles met the inclusion criteria. Most articles concerned retrospective studies and presented mixed data with other non–muscle-invasive bladder cancer categories. The evidence shows that new optical imaging modalities significantly increase the detection rate of CIS. BCG immunotherapy remains the first-line therapy in patients with CIS of the bladder; however, after treatment, adequate follow-up is necessary. Clinicopathological factors remain the main indicators of response to BCG, recurrence, and progression. Conclusions New optical imaging modalities are superior to white light cystoscopy in the detection of CIS of the bladder. There are no robust data that justify consideration of other agents as an alternative to BCG immunotherapy. Despite efforts to identify relevant biomarkers, clinicopathological factors remain the most important prognostic factors. Patient summary New optical techniques have improved the detection of carcinoma in situ (CIS) of the bladder. Bladder preservation using bacillus Calmette-Guérin immunotherapy remains the cornerstone of the treatment of CIS of the bladder." @default.
• W2940904211 created "2019-05-03" @default.
• W2940904211 creator A5002369232 @default.
• W2940904211 creator A5033224206 @default.
• W2940904211 creator A5060671936 @default.
• W2940904211 creator A5061349789 @default.
• W2940904211 creator A5070099238 @default.
• W2940904211 creator A5075855113 @default.
• W2940904211 creator A5075877183 @default.
• W2940904211 date "2020-07-01" @default.
• W2940904211 modified "2023-10-02" @default.
• W2940904211 title "Carcinoma In Situ of the Urinary Bladder: A Systematic Review of Current Knowledge Regarding Detection, Treatment, and Outcomes" @default.
• W2940904211 cites W1199133249 @default.
• W2940904211 cites W1538488400 @default.
• W2940904211 cites W1572827793 @default.
• W2940904211 cites W1578051988 @default.
• W2940904211 cites W1581418365 @default.
• W2940904211 cites W1684738998 @default.
• W2940904211 cites W1797887681 @default.
• W2940904211 cites W1900548187 @default.
• W2940904211 cites W1969919990 @default.
• W2940904211 cites W1972968831 @default.
• W2940904211 cites W1976576040 @default.
• W2940904211 cites W1980105555 @default.
• W2940904211 cites W1988104298 @default.
• W2940904211 cites W1993844636 @default.
• W2940904211 cites W1994309951 @default.
• W2940904211 cites W2017306423 @default.
• W2940904211 cites W2018489324 @default.
• W2940904211 cites W2020877136 @default.
• W2940904211 cites W2031185290 @default.
• W2940904211 cites W2053155246 @default.
• W2940904211 cites W2055972671 @default.
• W2940904211 cites W2057565712 @default.
• W2940904211 cites W2059804763 @default.
• W2940904211 cites W2060252726 @default.
• W2940904211 cites W2064500333 @default.
• W2940904211 cites W2072358888 @default.
• W2940904211 cites W2077436519 @default.
• W2940904211 cites W2077936479 @default.
• W2940904211 cites W2078228026 @default.
• W2940904211 cites W2080025643 @default.
• W2940904211 cites W2080770946 @default.
• W2940904211 cites W2082941803 @default.
• W2940904211 cites W2083458436 @default.
• W2940904211 cites W2084204019 @default.
• W2940904211 cites W2084541908 @default.
• W2940904211 cites W2090742614 @default.
• W2940904211 cites W2090808543 @default.
• W2940904211 cites W2091677923 @default.
• W2940904211 cites W2095399536 @default.
• W2940904211 cites W2098614234 @default.
• W2940904211 cites W2116195839 @default.
• W2940904211 cites W2126903040 @default.
• W2940904211 cites W2141736541 @default.
• W2940904211 cites W2152206210 @default.
• W2940904211 cites W2159059413 @default.
• W2940904211 cites W2159759416 @default.
• W2940904211 cites W2165626978 @default.
• W2940904211 cites W2327257129 @default.
• W2940904211 cites W2328983665 @default.
• W2940904211 cites W2377921056 @default.
• W2940904211 cites W2409048561 @default.
• W2940904211 cites W2411417005 @default.
• W2940904211 cites W2508239380 @default.
• W2940904211 cites W2588360654 @default.
• W2940904211 cites W2766194852 @default.
• W2940904211 cites W2768848125 @default.
• W2940904211 cites W2796621294 @default.
• W2940904211 cites W2892008540 @default.
• W2940904211 cites W2916183155 @default.
• W2940904211 cites W798685101 @default.
• W2940904211 doi "https://doi.org/10.1016/j.euf.2019.03.012" @default.
• W2940904211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30910393" @default.
• W2940904211 hasPublicationYear "2020" @default.
• W2940904211 type Work @default.
• W2940904211 sameAs 2940904211 @default.
• W2940904211 citedByCount "18" @default.
• W2940904211 countsByYear W29409042112020 @default.
• W2940904211 countsByYear W29409042112021 @default.
• W2940904211 countsByYear W29409042112022 @default.
• W2940904211 countsByYear W29409042112023 @default.
• W2940904211 crossrefType "journal-article" @default.
• W2940904211 hasAuthorship W2940904211A5002369232 @default.
• W2940904211 hasAuthorship W2940904211A5033224206 @default.
• W2940904211 hasAuthorship W2940904211A5060671936 @default.
• W2940904211 hasAuthorship W2940904211A5061349789 @default.
• W2940904211 hasAuthorship W2940904211A5070099238 @default.
• W2940904211 hasAuthorship W2940904211A5075855113 @default.
• W2940904211 hasAuthorship W2940904211A5075877183 @default.
• W2940904211 hasConcept C121608353 @default.
• W2940904211 hasConcept C126322002 @default.
• W2940904211 hasConcept C126894567 @default.
• W2940904211 hasConcept C143998085 @default.
• W2940904211 hasConcept C151730666 @default.
• W2940904211 hasConcept C168563851 @default.
• W2940904211 hasConcept C17744445 @default.
• W2940904211 hasConcept C189708586 @default.

• next